Low-cost ziv-aflibercept appears safe for intraocular administration
- Posted on: Nov 6 2017
A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent, is safe for treatment of retinal diseases.
Source: AAO
Posted in: AAO
